Skip to content

Drug interactions

Cyclobenzaprine + Olodaterol inhaled

Severity: Moderate

Cyclobenzaprine and Olodaterol inhaled: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cyclobenzaprine can prolong the QT interval and cause tachycardia, while olodaterol as a beta2-agonist can cause tachycardia, hypokalemia and QT changes. Combined use may increase the risk of ventricular arrhythmia in susceptible patients.

What this interaction means in plain words

Cyclobenzaprine and Olodaterol inhaled can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive QT prolongation and cardiostimulatory effects.

What to do

Monitor heart rate and rhythm, and correct potassium and magnesium abnormalities. Consider an ECG in patients with cardiac disease or other QT-prolonging drugs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cyclobenzaprine and Olodaterol inhaled, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cyclobenzaprine with Olodaterol inhaled?

MediHelp rates the interaction as moderate. Cyclobenzaprine and Olodaterol inhaled can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cyclobenzaprine can prolong the QT interval and cause tachycardia, while olodaterol as a beta2-agonist can cause tachycardia, hypokalemia and QT changes. Combined use may increase the risk of ventricular arrhythmia in susceptible patients.

How serious is the interaction between Cyclobenzaprine and Olodaterol inhaled?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate and rhythm, and correct potassium and magnesium abnormalities. Consider an ECG in patients with cardiac disease or other QT-prolonging drugs.

What other medicines interact with Cyclobenzaprine?

MediHelp also lists interactions of Cyclobenzaprine with, for example, Isocarboxazid, Linezolid, Phenelzine. The full list is on the Cyclobenzaprine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in